Clinical Trial Update: Dantrolene in Statin-induced Myopathy [Phase 2, Phase 3]

View source ↗

Summary

Dantrolene is being studied in Phase 2 and Phase 3 trials for statin-induced myopathy; recruitment has not yet begun.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Statin-induced Myopathy

Drugs mentioned

• Dantrium (dantrolene)

Snippet

Sponsor: Tanta University | Conditions: Statins Induced Myopathy | Phase 2, Phase 3 | Status: NOT_YET_RECRUITING